Teladoc Health, Inc. (FRA:4LL)

Teladoc Health Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,095	1,512	3,228	3,583	12,925	23,696
Market Cap Growth	-39.22%	-53.17%	-9.92%	-72.28%	-45.46%	338.83%
Enterprise Value	1,365	1,845	3,728	4,245	13,332	23,553
Last Close Price	6.04	8.96	19.86	22.20	79.92	163.92
PS Ratio	0.51	0.61	1.37	1.59	7.23	26.50
PB Ratio	0.92	1.05	1.53	1.66	0.92	1.83
P/FCF Ratio	4.59	5.53	10.54	22.16	79.26	-
P/OCF Ratio	4.39	5.33	10.19	20.23	75.77	-
EV/Sales Ratio	0.63	0.74	1.58	1.89	7.46	26.34
EV/EBITDA Ratio	57.56	60.21	94.47	-	-	-
EV/FCF Ratio	5.72	6.75	12.17	26.25	81.76	-
Debt / Equity Ratio	0.75	1.06	0.69	0.69	0.08	0.09
Debt / EBITDA Ratio	37.51	35.23	26.96	142.99	-	-
Debt / FCF Ratio	3.72	5.60	4.70	9.18	7.02	-
Asset Turnover	0.79	0.65	0.60	0.22	0.12	0.11
Inventory Turnover	19.86	22.21	17.70	11.50	10.04	-
Quick Ratio	2.34	1.62	3.22	2.89	3.28	2.87
Current Ratio	2.70	1.77	3.54	3.29	3.70	3.19
Return on Equity (ROE)	-15.42%	-52.46%	-9.51%	-148.85%	-2.69%	-5.74%
Return on Assets (ROA)	-3.48%	-3.30%	-3.01%	-1.23%	-0.84%	-2.70%
Return on Capital (ROIC)	-4.04%	-3.73%	-3.37%	-1.28%	-0.86%	-2.77%
Return on Capital Employed (ROCE)	-7.20%	-8.10%	-5.30%	-5.50%	-1.40%	-2.40%
Earnings Yield	-17.40%	-63.98%	-6.18%	-356.69%	-2.92%	-1.67%
FCF Yield	21.80%	18.08%	9.49%	4.51%	1.26%	-0.20%
Buyback Yield / Dilution	-3.59%	-3.64%	-1.93%	-2.88%	-73.40%	-25.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.